Refine by
Prostheses Articles & Analysis: Older
40 news found
These infections often require removal or exchange of prostheses and long-duration antibiotic treatment. We found that photodisinfection effectively eradicated important pathogens involved in PJI – whether in planktonic form or biofilms grown on commonly used arthroplasty materials – and without harming the prosthetic ...
Professor Jean-Benoît Thambo, head of the department of pediatric and congenital cardiology at the Bordeaux University Hospital, said to France3 how “these prostheses are the first phase of the medicine of tomorrow, a medicine that opts for material adapted to the body, biological”. ...
The presentation, “Safety and Efficacy of a Phase 1/2a Clinical Trial of Transplanted Allogeneic Retinal Pigmented Epithelium (RPE, OpRegen) Cells in Advanced Dry Age-Related Macular Degeneration (AMD)” was featured as part of the Retinal Prostheses and Transplantation Session, by Allen C. Ho, M.D., FACS, Wills Eye Hospital Attending Surgeon and Director of Retina ...
Similar to OpRegen, which has demonstrated to be able to replace and restore retinal pigment epithelium cells in patients with vision loss, and OPC1, which similarly replaces oligodendrocytes for the treatment of spinal cord injury, replacing auditory neurons or augmenting an existing but damaged auditory neuron population may provide a benefit beyond the reach of alternate approaches such as ...
Earlier receipt of a prosthesis is associated with reduced spending in the 12 months post-amputation of approximately $25,000 compared with not receiving a prosthesis. The results of this study suggest that not providing or delaying the provision of a prosthesis increases costs by about 25%. iFIT can help facilitate fitting patients soon after amputation with the ability to be fit anywhere ...
Anteris Technologies Ltd (ASX: AVR) reports the first-in-human DurAVR™ THV study met or exceeded its interim study objectives. At the 30-day follow up point, the first five patients of the planned 10-patient study showed: All five subjects continued to do well with no reported adverse events (no death, stroke, myocardial infarction, reintervention). An average 86% improvement in mean ...
Method: Retrospective observational study on 4,578 Veterans hospitalized for LLA and discharged 2003- 2004, looking at time to all-cause mortality from the amputation surgical date up to the 3 yr anniversary. Results: 1,300 (28.4%) persons received a prescription for a prosthetic limb within 1 yr after the surgical amputation. About 46% (n = 2,086) of all Veterans w LLA died within 3 yr of the ...
CARMAT (FR0010907956, ALCAR), the designer and developer of the world’s most advanced total artificial heart, aiming to fulfill an unmet medical need by providing a therapeutic alternative to people suffering from end-stage biventricular heart failure, announces the completion of investigations on its prostheses. Following the occurrence of a quality issue affecting some ...
ByCarmat
Following the occurrence of a qualityissueaffecting some of its prostheses, the Company has decided to temporarily suspend, as a precautionary measure, implantsof its Aeson® artificial heart. ...
ByCarmat
This patient reduced their volume within a month period of time using the iFIT transtibial prosthesis. The iFIT system relieves swelling and shapes the limb quickly. There is no need to wait for prosthetic shrinker socks to reduce volume, so those with limb loss can be fit right away and get back on their feet. ...
Scott has more than two decades of experience in the medical technology industry, including with prosthetic heart valves, heart valve repair, orthopedic surgery, stents, blood pumps, TETS, robotic prostheses / orthoses and many more. His work in this industry has included countless IP diligence evaluations in the contexts of IPOs, strategic acquisitions and investments, joint ...
CARMAT (FR0010907956, ALCAR), the designer and developer of the world’s most advanced total artificial heart, aiming to fulfill an unmet medical need by providing a therapeutic alternative to people suffering from end-stage biventricular heart failure, today provides an update on its early feasibility study (EFS) in the United States. The FDA has granted CARMAT approval to use the new ...
ByCarmat
Addressable market in the bridge-to-transplant indication of more than 2,000 patients a year in Europe Company prepares for commercial launch in Q2 2021, with initial focus on Germany and France Robust clinical plan to support adoption and sales development Virtual conference with Stéphane Piat today at 5 pm CET CARMAT (FR0010907956, ALCAR), the designer and developer of the ...
ByCarmat
APrevent announced on 7TH December that APrevent and Labostera signed the distribution agreement for APrevent® VOIS in Lithuania. We are going to provide patients with glottic insufficiency/unilateral vocal fold paralysis an innovative, safe and effective surgical treatment. Labostera was founded in year 2005, they are experienced in ENT surgical products including surgical voice ...
BioAesthetics hopes the NACgraft will improve the quality-of-life — including improved body-image and other positive psychological impacts — of those choosing to undergo breast reconstruction, as current available nipple reconstruction options such as prostheses, tattoos, and skin flap reconstructions have often-unsatisfactory results. ...
With attractive tax incentives and our special financing option, the timing to purchase an Ortis system cannot get better: 1. Covid-19 Payment Deferment Program By financing your equipment purchase through our banking partners, you can take advantage of a special financing option: $0 down payment $0 payment for the first 6 months Simply put, you can acquire this technology for only $0 ...
“Given the often-unsatisfactory results of current NAC reconstruction options like prostheses, tattoos, and skin flap reconstructions, it is our hope that the NACgraftTM will improve the quality-of-life — including improved body-image and other positive psychological impacts — of those patients choosing to undergo breast ...
Vilex, LLC, a member of the Squadron Capital family of businesses, announced today that it has successfully completed the acquisition of DT MedTech, LLC, whose product lines include the Hintermann Series System™ Total Ankle Replacement (TAR), developed by prominent surgeon, Professor Beat Hintermann. This exceptional TAR system includes the Hintermann Series H3 (H3) 3-piece, mobile-bearing ...
VEO Ophthalmics, LLC announced today that, in honor of Rare Disease Day, it is collaborating with the Masket Foundation to raise awareness of aniridia and treatment options for aniridia. Aniridia is a serious ophthalmic rare disease in which a patient’s iris does not develop properly. VEO Ophthalmics is the U.S. distributor for the CUSTOMFLEX® ARTIFICIALIRIS, a custom-made artificial ...
Neuchâtel, Switzerland, January 14, 2020 – Novostia announces that it has been awarded EUR 2.5 million grant from the European Union under the highly competitive Horizon 2020 EIC Accelerator. The EIC Accelerator is part of the European Innovation Council (EIC) pilot that supports top class companies with funding opportunities and acceleration services to help them develop and bring ...